STAT

SEPTEMBER 18, 2024

patent system by the pharmaceutical industry, moves by some drugmakers to expand their patent claims appear to be delaying the arrival of lower-cost generic medicines to the marketplace, according to a STAT analysis.  Amid debate over potential abuse of the U.S.

Generic Medicine 352

Generic Medicine Drug Pricing 352

STAT

DECEMBER 4, 2024

Specifically, the proposed rule was crafted to stem the use of so-called patent thickets , which are wielded by drug companies to delay the arrival of lower-cost generic medicines in the marketplace.

Generic Medicine 294

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 294

STAT

JUNE 17, 2024

Patent and Trademark Office has proposed a new rule designed to stem the use of so-called patent thickets , which are wielded by pharmaceutical companies to delay the arrival of lower-cost generic medicines in the marketplace.

Generic Medicine 320

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 320

STAT

MAY 23, 2023

The chemo drug in question, Imatinib, costs $17,000 at CVS and just $72 at Cost Plus Drugs. But it’s a generic medicine — which means PBMs’ negotiating techniques don’t apply. Generic drugs compete on price. Continue to STAT+ to read the full story…

Generic Medicine 246

Generic Medicine Drug Pricing 246

Pharmaceutical Technology

DECEMBER 15, 2022

Inflation can damage production viability of European drugs. Once a drug’s patent expires, numerous pharma companies offer generic versions, which can then reduce drug pricing by as much as 80-90%, leading to small profit margins for generics makers.

Generic Medicine 98

Generic Medicine Drug Pricing Biosimilars Hospitals 98

Express Pharma

SEPTEMBER 6, 2023

In a bid to resolve both physical and financial restrictions inhibiting equitable access to quality medicines, the Jan Aushadhi scheme was launched in 2008 and envisaged the setting up of dedicated Janaushadhi Kendras to provide quality generic medicines at capped prices for the general public.

Insurance Coverage and Processing 59

Insurance Coverage and Processing Biosimilars Generic Medicine Drug Pricing 59

pharmacy mentor

AUGUST 22, 2024

The deductions work as follows: Branded Medicines (Part VIIIA Category C) : 5% discount Generic Medicines (Part VIIIA Categories A and M) : 20% discount Appliances (Part IX) : 9.85% discount Understanding these deductions is critical, especially when many medicines are unavailable at or below the Drug Tariff price.

Community Pharmacies 52

Community Pharmacies Generic Medicine Drug Pricing Documentation 52